Package 25021-615-51

Brand: dexmedetomidine hydrochloride in 0.9% sodium chloride

Generic: dexmedetomidine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 25021-615-51
Digits Only 2502161551
Product NDC 25021-615
Description

10 BOTTLE in 1 CARTON (25021-615-51) / 100 mL in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2024-02-15
Brand dexmedetomidine hydrochloride in 0.9% sodium chloride
Generic dexmedetomidine hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "18a919fe-92bd-4e01-a966-7334eb31b844", "openfda": {"unii": ["1018WH7F9I"], "rxcui": ["1718906", "1718909"], "spl_set_id": ["a99335d0-1e87-4180-bde3-cbb12bf91a52"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BOTTLE in 1 CARTON (25021-615-50)  / 50 mL in 1 BOTTLE", "package_ndc": "25021-615-50", "marketing_start_date": "20240215"}, {"sample": false, "description": "10 BOTTLE in 1 CARTON (25021-615-51)  / 100 mL in 1 BOTTLE", "package_ndc": "25021-615-51", "marketing_start_date": "20240215"}], "brand_name": "Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride", "product_id": "25021-615_18a919fe-92bd-4e01-a966-7334eb31b844", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]", "General Anesthesia [PE]"], "product_ndc": "25021-615", "generic_name": "dexmedetomidine hydrochloride", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride", "active_ingredients": [{"name": "DEXMEDETOMIDINE HYDROCHLORIDE", "strength": "4 ug/mL"}], "application_number": "ANDA217308", "marketing_category": "ANDA", "marketing_start_date": "20240215", "listing_expiration_date": "20261231"}